نتایج جستجو برای: hcv antibody

تعداد نتایج: 186289  

2017
Amr Kandeel Mohamad Genedy Samir El‐Refai Anna L. Funk Arnaud Fontanet Maha Talaat

BACKGROUND & AIMS In 2015, a national Egyptian health issue survey was conducted to describe the prevalence of hepatitis C virus (HCV) infection. In this paper, we describe the HCV burden in 2015, compare the results with the national survey conducted in 2008, and discuss the implications of the new findings on prevention of HCV in Egypt. METHODS A multistage probability sampling approach was...

2017
Mwumvaneza Mutagoma Helene Balisanga Dieudonné Sebuhoro Aimable Mbituyumuremyi Eric Remera Samuel S. Malamba David J. Riedel Sabin Nsanzimana

BACKGROUND Hepatitis C virus (HCV) infection is a pandemic causing disease; more than 185 million people are infected worldwide. An HCV antibody (Ab) prevalence of 6.0% was estimated in Central African countries. The study aimed at providing HCV prevalence estimates among pregnant women in Rwanda. METHODS HCV surveillance through antibody screening test among pregnant women attending antenata...

Journal: :Indian journal of medical microbiology 2005
A K Reddy K V D Murthy V Lakshmi

PURPOSE The present study was undertaken to determine the prevalence of HCV infection by antibody testing and HCV core antigen (HCVcAg) determination by ELISA in haemodialysis patients and to evaluate the HCV c Ag assay in the detection of HCV infected patients on haemodialysis. MATERIALS AND METHODS A total of 151 chronic renal failure patients on haemodialysis from May 2003 to October 2004 ...

2018
Pin-Nan Cheng Yen-Cheng Chiu Hung-Chih Chiu Shih-Chieh Chien

BACKGROUND Control of hepatitis C virus infection (HCV) is an increasingly important issue. Enhancing screening coverage is necessary to discover more HCV infected subjects in community. However, a substantial population is unaware of HCV infection that needs more attention. AIM The aims of this study were to evaluate the status of HCV infected residents in remote villages, to compare charact...

A. Behzad-Behbahani A. Mafi-Nejad A. Torab A.R. Salah B. Pourabbas K.B. Lankarani M. Rashidi M. Rasouli S.Z. Tabei

Background: In spite of available, and sensitive screening assay for detection of hepatitis B virus surface antigen (HBsAg), occasional cases of post-transfusion hepatitis B virus infection are still observed. The aim of the present study was to assess the prevalence of positive anti hepatitis B core (anti-HBc) and presence of HBV-DNA in serum sample of healthy blood donors negative for both HB...

Journal: :Hepatology 2008
Mirjam B Zeisel François-Loïc Cosset Thomas F Baumert

The recent development of novel model systems for the early steps of hepatitis C virus (HCV) infection has rapidly advanced our knowledge of antibody-mediated virus neutralization in patients with acute and chronic hepatitis C. This review summarizes our current understanding of host neutralizing responses during the course of HCV infection. It focuses on recent studies in HCV-infected patients...

Journal: :Acta medica Okayama 2004
Toshiyuki Shinji Yi Yi Kyaw Katsunori Gokan Yasuhito Tanaka Koji Ochi Nobuchika Kusano Takaaki Mizushima Shin-ichi Fujioka Hidenori Shiraha Aye Aye Lwin Yasushi Shiratori Masashi Mizokami Myo Khin Masayuki Miyahara Shigeru Okada Norio Koide

The prevalence of hepatitis C virus (HCV) genotypes in Myanmar in comparison with the rest of Southeast Asia is not well known. Serum samples were obtained from 201 HCV antibody-positive volunteer blood donors in and around the Myanmar city of Yangon. Of these, the antibody titers of 101 samples were checked by serial dilution using HCV antibody PA test II and Terasaki microplate as a low-cost ...

کمالی, نگار, حافظی, رضا, فرشته‌نژاد, سید محمد, کمالی, کوشا,

    Background and Aim: Chronic liver disease and its complications are major problems in renal transplant recipients. Hepatitis B and C virus infections are currently the main causes of chronic liver disease in this group, and these may affect allograft outcome. Whether hepatitis B and C virus infections after renal transplantation adversely affect graft and patient survival, remains controver...

Journal: :Australian and New Zealand journal of public health 2014
Fiona L Shand Carolyn Day William Rawlinson Louisa Degenhardt Nicholas G Martin Elliot C Nelson

BACKGROUND In Australia about half of the people who inject drugs (PWID) are hepatitis C (HCV) antibody positive (anti-HCV+). The prevalence among opioid substitution treatment (OST) clients specifically is unclear, despite OST clinics being a potential setting for HCV care. This study aimed to report the prevalence of HCV among a large sample of NSW OST clients, understand whether HCV testing ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید